ESG indices, products faring relatively better in coronavirus responseBY RACHEL ALEMBAKIS | FRIDAY, 27 MAR 2020 2:18PMIn the immediate financial markets response to the coronavirus pandemic and the associated implosion to the global economy, indices and products that integrate ESG ratings have performed relatively better than mainstream benchmarks. Related News |
Editor's Choice
Genetic testing ban takes effect for life insurance
Australian's can access genetic testing without risking discrimination in life insurance under a new ban that took effect on October 8, with the Australian Financial Complaints Authority (AFCA) also updating its rules to handle complaints involving adverse genetic test results.
Australian Ethical sharpens private markets focus
Australian Ethical Investment is expanding its private markets capabilities and deepening its focus on measurable impact.
Climate 'critical' for 60% of APAC investors, just 27% in US: Robeco
Robeco's 2026 Global Climate Investing Survey of 300 institutional and wholesale investors, managing around US$35.8 trillion, found 56% of APAC investors said climate change is central to their investment policy.
Banks face scrutiny over deforestation exposure
Australia's major banks are facing renewed scrutiny over their exposure to deforestation, with new analysis from the Australian Conservation Foundation (ACF) linking mortgages held by lenders to more than 16,500 hectares of forest clearing.
Further Reading



